Blue Cross Blue Shield North Carolina November 2017 Medical Policy Updates

Click here to view the Blue Cross Blue Shield North Carolina November 2017 Medical Policy Updates »

Medical Policy Updates for November 10 2017:

• Allogeneic Hematopoietic Transplant for Genetic Diseases and Acquired Anemia
• Antiprothrombin Antibody Testing
• Artificial Intervertebral Disc
• Axial Lumbosacral Interbody Fusion
• Botulinum Toxin Injection
• Cardiac Hemodynamic Monitoring in the Outpatient Setting
• Carotid Intimal-Medial Thickness
• Computed Tomography to Detect Coronary Artery Calcification
• Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)
• Dental Criteria for use of Hospital Inpatient or Outpatient Facility Services or Ambulatory Surgery Center Facility Services
• Dental Reconstructive Services
• Edaravone (Radicava^TM)
• Erythropoiesis-Stimulating Agents (ESAs)
• Extracorporeal Photopheresis
• Genetic Cancer Susceptibility Panels Using Next Generation Sequencing
• Genetic Testing for Alzheimer’s Disease
• Genetic Testing for Dilated Cardiomyopathy
• Genetic Testing for Epilepsy
• Genetic Testing for Heterozygous Familial Hypercholesterolemia
• Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy
• Hyperthermia Therapy
• Interferential Stimulation
• Magnetoencephalography/Magnetic Source Imaging
• Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
• Molecular Panel Testing of Cancers to Identify Targeted Therapies
• MRI-guided Laser-induced Thermotherapy for Neurological Indications
• Navigated Transcranial Magnetic Stimulation (nTMS)
• Neurostimulation, Electrical
• Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell-Free Fetal DNA
• Nusinersen (Spinraza^TM)
• Orthodontics for Pediatric Patients
• Orthognathic Surgery
• Percutaneous Electrical Nerve Stimulation (PENS) or Neuromodulation Therapy
• Peripheral Arterial Tonometry (PAT)
• Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
• Pulmonary Hypertension, Drug Management
• Serum Biomarker Panel Testing for Systemic Lupus Erythematosus
• Signal-Averaged ECG
• Spinal Cord Stimulation
• Stem-cell Therapy for Peripheral Arterial Disease
• Temporomandibular Joint Dysfunction (TMJD)
• Total Facet Arthroplasty
• Vagus Nerve Stimulation
• Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders

Click here to view the Blue Cross Blue Shield North Carolina November 2017 Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.